Khalan Y, Kaveh M, Karimi M, Zare E, Asadollahi A
BMC Public Health. 2025; 25(1):856.
PMID: 40038646
PMC: 11877681.
DOI: 10.1186/s12889-025-22067-x.
Kale S, Rush L, Eramo J, Bitangacha M, Chen S, Check D
Support Care Cancer. 2025; 33(2):146.
PMID: 39903305
PMC: 11794404.
DOI: 10.1007/s00520-025-09181-7.
Ritter A, Barrett L
Harm Reduct J. 2024; 21(1):215.
PMID: 39617904
PMC: 11610087.
DOI: 10.1186/s12954-024-01132-5.
Bulgin D, McBride Murry V, McElroy T, Schlundt D, Bonnet K, Patrick S
Womens Health Issues. 2024; 35(1):45-53.
PMID: 39603927
PMC: 11851233.
DOI: 10.1016/j.whi.2024.10.003.
Asad M, Bonner-Reid F, Aldoohan F, Marrelli L, Ghanie N, Attia Hussein Mahmoud H
Cureus. 2024; 16(10):e72192.
PMID: 39583351
PMC: 11583522.
DOI: 10.7759/cureus.72192.
Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial.
Weinstein Z, Yu O, Wartko P, Samet J, Bobb J, Braciszewski J
Drug Alcohol Depend. 2024; 265:112497.
PMID: 39550823
PMC: 11608535.
DOI: 10.1016/j.drugalcdep.2024.112497.
Leveraging Trauma Informed Care for Digital Health Intervention Development in Opioid Use Disorder.
Venkatasubramanian K, Appleton J, Ranalli T, Mankodiya K, Solanki D, Carreiro S
J Med Toxicol. 2024; 21(1):60-68.
PMID: 39446308
PMC: 11706808.
DOI: 10.1007/s13181-024-01040-x.
Public perceptions of opioid misuse recovery and related resources in a nationally representative sample of United States adults.
Golan O, Kresovich A, Drymon C, Ducharme L, Flanagan Balawajder E, Borowiecki M
Addiction. 2024; 120(2):253-265.
PMID: 39428591
PMC: 11710964.
DOI: 10.1111/add.16692.
The intersection of substance use stigma and anti-Black racial stigma: A scoping review.
Ghonasgi R, Paschke M, Winograd R, Wright C, Selph E, Banks D
Int J Drug Policy. 2024; 133:104612.
PMID: 39369573
PMC: 11571710.
DOI: 10.1016/j.drugpo.2024.104612.
Reframing conceptualizations of primary care involvement in opioid use disorder treatment.
Chiu K, Sud A
BMC Prim Care. 2024; 25(1):356.
PMID: 39350088
PMC: 11443781.
DOI: 10.1186/s12875-024-02607-x.
Integrating Nursing Practice and Policy in Opioid Overdose Prevention: Analysis of the Opioid-Overdose Reduction Continuum of Care Approach Practice Guide.
Kyei E, Ansong R, Kyei G
J Adv Nurs. 2024; 81(3):1276-1285.
PMID: 39253795
PMC: 11810498.
DOI: 10.1111/jan.16451.
Household Income Is Associated with Chronic Pain and High-Impact Chronic Pain among Cancer Survivors: A Cross-Sectional Study Using NHIS Data.
Valvi N, Tamargo J, Braithwaite D, Fillingim R, Karanth S
Cancers (Basel). 2024; 16(16).
PMID: 39199618
PMC: 11353052.
DOI: 10.3390/cancers16162847.
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder.
Freet C, Evans B, Brick T, Deneke E, Wasserman E, Ballard S
Addict Sci Clin Pract. 2024; 19(1):56.
PMID: 39061093
PMC: 11282646.
DOI: 10.1186/s13722-024-00481-7.
Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State.
Kruger D, Kirk H, Leonard K, Lynch J, Nielsen N, Collins R
Harm Reduct J. 2024; 21(1):134.
PMID: 39004729
PMC: 11247824.
DOI: 10.1186/s12954-024-01045-3.
Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality.
Laing R, Donnelly C
PLoS One. 2024; 19(7):e0306395.
PMID: 38980856
PMC: 11233025.
DOI: 10.1371/journal.pone.0306395.
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis.
Couch J, Whitcomb M, Buchheit B, Dorr D, Malinoski D, Korthuis P
Harm Reduct J. 2024; 21(1):125.
PMID: 38937779
PMC: 11210005.
DOI: 10.1186/s12954-024-01043-5.
Advancing opioid stewardship in low-middle-income countries: challenges and opportunities.
Jadhari R, Pathak N, Shrestha R, Shrestha S, Kc B, Gan S
J Pharm Policy Pract. 2024; 17(1):2345219.
PMID: 38845626
PMC: 11155429.
DOI: 10.1080/20523211.2024.2345219.
"Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking in the United States.
Koehm K, Rosen J, Yedinak Gray J, Tardif J, Thompson E, Park J
Subst Use Addctn J. 2024; 45(4):682-689.
PMID: 38804608
PMC: 11458346.
DOI: 10.1177/29767342241253663.
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol.
Khazaee-Pool M, Naghibi S, Pashaei T, Ponnet K
Addict Sci Clin Pract. 2024; 19(1):40.
PMID: 38755676
PMC: 11097512.
DOI: 10.1186/s13722-024-00472-8.
The relationship between felt stigma and non-fatal overdose among rural people who use drugs.
Sibley A, Klein E, Cooper H, Livingston 3rd M, Baker R, Walters S
Harm Reduct J. 2024; 21(1):77.
PMID: 38582851
PMC: 10998326.
DOI: 10.1186/s12954-024-00988-x.